Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 14, 2002

View Archived Issues

Novel 5-HT1B antagonists with utility in depression identified at GSK

New adenosine A1 agonists discovered by GSK researchers

Merck scientists present novel inhibitors of factor Xa and/or factor VIIa

Sankyo describes the isolation of new antifungal agents from Phoma sp.

Series of integrin antagonists for asthma and other disorders prepared at Merck & Co.

Cholesterol-lowering efficacy of SMP-500, a novel ACAT inhibitor, in hyperlipidemic hamsters

Oregovomab enhances killer T-cell responses in apoptotic ovarian cancer cells

Pretreatment of solid tumors with NHS76/PEP2 improves efficacy of chemotherapy in mice

Emodin accelerates pancreatic regeneration in acute pancreatitis in rats

Orally active 5-HT2C receptor agonist synthesized at Vernalis as potential antiobesity agent

SLV-314: neurochemical and behavioral effects detailed at Neuroscience 2002

Binding profile of atypical antipsychotic agent SM-13496

Exanta proves superior to routinely used enoxaparin for reducing risk of VTE in major surgery

Oprelvekin reported to increase platelet counts in hepatitis C patients

Potential novel use for PPARgamma agonists discussed at AASLD meeting

Improved safety profile reported for ribavirin prodrug viramidine

Potential use of the antisense oligonucleotide ISIS-14803 in chronic HCV

Commit lozenge approved by the FDA for over-the-counter sale

Drug safety announcement regarding Refludan

Seattle Genetics releases clinical and preclinical updates

Recombinant alpha 1-antitrypsin topical gel enters clinical trials

Accelerated approval plan for KRX-101

Johnson & Johnson to acquire OraPharma

Serono and Amgen sign license agreement for multiple sclerosis product

Vertex advances Aurora kinase inhibitor into preclinical development

Immtech International completes efficacy trials of DB-289

Phase II clinical trial initiated to evaluate the efficacy of 17beta-estradiol against restenosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...